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Abstract 
Introduction: Recovery from serious mental illness has historically not been considered a likely 
or even possible outcome. However, a range of evidence suggests the courses of SMI are 
heterogeneous with recovery being the most likely outcome. One barrier to studying recovery in 
SMI is that recovery has been operationalized in divergent and seemingly incompatible ways, as 
an objective outcome, versus a subjective process.  
Areas Covered: This paper offers a review of recovery as a subjective process and recovery as 
an objective outcome; contrasts methodologies utilized by each approach to assess recovery; 
reports rates and correlates of recovery; and explores the relationship between objective and 
subjective forms of recovery.  
Expert Commentary: There are two commonalities of approaching recovery as a subjective 
process and an objective outcome: (i) the need to make meaning out of one’s experiences to 
engage in either type of recovery and (ii) there exist many threats to engaging in meaning 
making that may impact the likelihood of moving toward recovery. We offer four clinical 
implications that stem from these two commonalities within a divided approach to the concept of 
recovery from SMI. 
Key words: serious mental illness, recovery, remission, recovery-oriented practice, 
outcomes 
3 
Due to many factors, including persistent pessimism among mental health professionals 
and divergent views on the nature and course of serious mental illness (SMI), recovery from 
serious mental illness was historically not considered a likely or even possible outcome. SMI is 
an umbrella term that includes multiple diagnostic categories that share similar levels of 
disability [1,2], however this pessimism is particularly prominent in views of schizophrenia and 
thus much of the research has focused on schizophrenia. For example, once influential 
Kraepliniean models of schizophrenia considered schizophrenia to be a deteriorating illness. In 
this view “stability” was cast as the most positive outcome from schizophrenia such that those 
who did recover were assumed to be incorrectly diagnosed.  
A series of quantitative and qualitative studies, however, provide considerable evidence 
that SMI does not follow one course characterized by lifelong dysfunction. Instead, tracking 
individuals with SMI for extended periods has repeatedly shown a variety of outcomes. These 
studies indicate that even amongst the most severely ill, individuals were more likely than not to 
recover in many meaningful ways, frequently achieving symptom remission and a return to 
functioning [3-8]. In parallel, first person reports and qualitative studies of the subjective 
experience of SMI recovery [e.g. 9-13] portray a complementary set of recovery outcomes. 
These works consistently report that despite bewildering symptoms, experiences of stigma, 
demoralization, and trauma, persons with SMI are able to recover a sense of dignity, hope, self-
direction, coherent sense of identity, and the achievement of an acceptable quality of life. These 
findings emphasize the necessity of examining dimensions of wellbeing beyond symptom 
remission. 
Taken together, the earlier amongst these studies helped spark a grassroots movement in 
the 1980s and 1990s that ushered in a new conceptualization of what the outcomes for those with 
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SMI should entail [14]. The recovery movement signified a paradigm shift in the 
conceptualization and treatment of SMI, and as with any paradigm shift, raised many questions 
for scientists, practitioners, and consumers alike. Response to these questions included a widely-
cited definition offered by Anthony [15] describing recovery as “a deeply personal, unique 
process of changing one’s attitudes, values, feelings, goals, skills, and/or roles. It is a way of 
living a satisfying, hopeful, and contributing life even with the limitations caused by illness” [p. 
527]. In 2005, there was a seminal meeting by SAMHSA [16] involving panelists from divergent 
backgrounds who developed a list of 10 essential elements of recovery: Self-direction, 
Individualized, Empowerment, Holistic, Non-linear, Strengths-based, Peer Support, Respect, 
Responsibility and Hope.   
The recovery paradigm has also raised important questions concerning how often 
recovery occurs and what helps and hinders recovery outcomes. To address these questions, 
Silverstein and Bellack [17] summarized two decades of research on recovery. They noted, 
however, that beyond establishing that recovery is a meaningful and realistic outcome, that this 
literature was beset by confusion regarding how recovery should be defined and measured. In 
response, they identified four areas of research and development:  1) the definition of recovery; 
2) the development of reliable measures of recovery; 3) rates of and barriers to recovery; and 4)
the effectiveness of recovery-oriented care. 
Since this important review, the volume of work on recovery from SMI has significantly 
increased. In this review, we explore the ways in which the literature following Silverstein and 
Bellack’s [17] review has defined and measured recovery. The current paper is an attempt to 
explore the newly emerging literature as well as to consider divergent views of recovery, and 
will be divided into six sections. First, we will focus on the emergence to two distinct ways of 
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defining recovery: recovery as a subjective process and recovery as an objective outcome. 
Second, we will contrast the methodologies both approaches employ to measure recovery. Third, 
we will present findings regarding the rates and correlates of recovery. Fourth, we will explore 
the relationship of objective and subjective forms of recovery. Fifth, in our commentary, we will 
discuss two commonalities of approaching recovery as a subjective process and an objective 
outcome in an attempt to bridge the divergent views and will discuss four implications for 
recovery oriented care. Finally, a view of key needs for future research will be offered.  
Our review was based on literature searches utilizing PubMed, SCOPUS, PsycInfo, and 
EBSCO databases with search terms schizophrenia, recovery, outcome, treatment, serious mental 
illness, remission, and process. We included articles that had been published since Silverstein 
and Bellack’s [17] article as well as foundational articles contributing to the history and course 
of the recovery movement in SMI. In an effort to capture a larger sense of the recovery literature, 
we chose not to limit the review to articles focused solely on schizophrenia, instead including a 
number of relevant articles pertaining to SMI as a more general category. Abstracts were 
examined to determine if the article presented findings regarding recovery or remission rates, 
recovery outcomes, recovery-oriented care, or definitions of recovery. Articles including 
information on these topics are in the following review.  
1. Review
1.1 Contrasting Views of Recovery as a Subjective Process and as an Objective Outcome 
In their 2008 review of literature on recovery from SMI, Silverstein and Bellack [17] 
noted a primary barrier to the study of recovery was differing definitions of the concept of 
recovery. They suggested one set of work conceptualized recovery as an outcome occurring after 
a successful treatment or series of gains made by the person diagnosed with SMI while a second 
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set discussed recovery as something that emerged as a person made their way through life. This 
view was in part an evolution of Davidson and Roe [18] who identified two distinct uses of the 
word recovery: recovery from illness (i.e., outcome), and being in recovery (i.e., process). 
Davidson and Roe [18] further distinguished these approaches by the type of person who was 
responsible for determining whether recovery had occurred. Recovery as an outcome was 
naturally dependent upon a determination made by someone other than the individual (e.g. a 
clinician rating of symptom severity) while recovery as a process places primary emphasis on the 
subjective experiences of the person. Although this division of recovery definitions reflects a 
prominent demarcation in the literature, other models have been proposed, including a 
conceptualization of recovery as consisting of three elements: cure, illness management, and 
personal recovery [19]. For the sake of this review we will focus on the more prevalent divide 
with views falling into either subjective process or objective outcome, but acknowledge that 
there are some who have proposed models that fall somewhat outside this dichotomy.  
Since 2008, the general divide between process and outcome has continued; for example 
Kane [20] framed recovery as an outcome and proposed that it is the product of a number of 
steps beginning with successful engagement in pharmacological treatment, which leads to the 
remission of symptoms, and finally recovery as defined by achieving specific outcomes 
observable by others within a time frame (e.g. successful levels of psychosocial function for two 
years). Notable in this view is that clinicians have primary responsibility in terms of making 
accurate appraisals regarding whether the client achieves recovery, and that recovery is defined 
by a level of functioning and the remission of symptoms rather than on the subjective 
experiences of the individual experiencing SMI. These approaches tend to rely on traditionally 
paternalistic views of SMI and often neglect the considerable disagreement between providers 
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and clients with regard to clients’ quality of life, as clients tend to report better outcomes than 
their providers [21,22]. 
In contrast to this, is a different approach often carried out by phenomenologists, 
advocates, and persons diagnosed with mental illness themselves [23,24]. Summarizing this 
work, Slade and Longden [25] frame recovery as something subjective and unique across 
different persons. They refer to this as “personal recovery” and frame it as a process defined and 
assessed by the person themselves. They argue that this is in contrast to the view focused on 
remission, and instead emphasize commonalities across human experience, such as experiencing 
struggles and searching for fulfillment. They question the need for acceptance of a diagnosis to 
achieve recovery. Support for this model can be found in direct interviews with persons with 
SMI. Further evidence comes from Law and Morrison [26] which compiled understandings of 
recovery from 381 persons who had personal experience of SMI and which emphasized a 
personally acceptable quality of life. 
Synthesizing this work, Drake and Whitely [27] call attention to the dangers of this 
divide, arguing that “the rapid proliferation of definitions, models, and research on recovery 
makes it vitally important to examine the data to disentangle the evidence from the rhetoric” [p. 
237]. Like Slade and Longden [25], they emphasize that the view of recovery as an outcome 
neglects data from autobiographical studies that the experience of recovery involves gaining a 
sense of agency and autonomy in the face of difficulties. They further note that any treatment 
which progresses without concern for the experiences of individuals utilizing treatment risks its 
outcomes being meaningless. Offering empirical evidence of the divided views of recovery, 
Karow et al. [28] interviewed 131 persons diagnosed with schizophrenia, their family members, 
and psychiatrists regarding perceptions of remission. They found agreement in less than 20% 
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across the three groups, with different experiences being offered different weights by each group. 
For example, persons diagnosed with SMI valued subjective well-being substantially more than 
other outcomes such as symptom reduction. Similarly, Kuhnigk et al. [29] interviewed 105 adults 
diagnosed with mental illness, 160 physicians, 50 relatives of persons diagnosed with mental 
illness, and 30 payers responsible for the costs of care, regarding their appraisal of the most 
important outcomes.  Not surprisingly, groups differed in their ratings with pairwise agreement 
ranging from 38.9% to 63.3% and rank correlations ranging from 0.43 to 0.51. The authors echo 
Drake and Whitley’s [27] comments, though in a more optimistic manner, and recommend that 
stakeholders better understand each other’s preferences. 
Divergent definitions of recovery have thus led to a range of measurement methods and 
conceptualizations of outcome. We will review each, with consideration for how recovery was 
defined. Of note, we find problems with the terms objective recovery vs subjective recovery and 
use of these terms warrants consideration. The field uses the term “objective” to refer to 
judgments made by clinicians, often in contrast to judgments made by the individual 
experiencing mental illness, referred to as “subjective.” Our use of these terms is not intended to 
suggest that judgments made by professional staff are more valid or reliable than those of the 
individual involved. Rather, these are two different angles of looking at an individual’s 
experience and functioning and one should not be privileged above the other. 
1.2 Methodological Approaches for Defining Recovery as an Objective Outcome 
Despite symptom remission being a primary focus of recovery as an objective outcome, 
there are considerable differences among operational definitions. The most commonly used 
assessments of symptoms in schizophrenia are the Positive and Negative Syndrome Scale 
[PANSS; 30], the Scale for Assessment of Positive Symptoms [SAPS; 31], the Scale for the 
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Assessment of Negative Symptoms [SANS; 32], and the Brief Psychiatric Rating Scale [BPRS; 
33]. To operationalize symptom remission, the Remission in Schizophrenia Working group has 
developed criterion for remission for each of these scales [34]. For the PANSS, symptom 
remission was defined as six months of having ratings of no more than mild levels on the 
PANSS symptom scales. Remission on the BPRS was defined similarly as mild or lesser levels 
of symptoms for at least a period of six months. For SANS and SAPS, remission was defined as 
mild or less levels of symptoms. 
To capture objective markers of recovery in terms of psychosocial functioning, the most 
widely used instrument was the Global Assessment of Functioning [GAF; 35]. The GAF is a 100 
point scale that offers scores of functioning based on psychological, social, and occupational 
functioning. Across studies, recovery as assessed with the GAF has been generally defined by a 
rating of “81” or higher. This rating reflects “absent or minimal symptoms” and is thought to 
describe overall good functioning with little to no impairment from mental health symptoms.  
Other common measures to assess psychosocial functioning include the Social 
Occupational Functioning Assessment Scale [SOFAS; 36], the Personal and Social Performance 
Scale [PSP; 37], the Social Adjustment Scale-II [SAS-II; 38], and the SF-36 [39]. Similar to the 
GAF, the SOFAS offers a score based only on social and occupational functioning, independent 
of overall symptoms. The range of scores falls from 0-100, with higher scores reflecting better 
functioning. The PSP is an adaptation of the SOFAS and offers a score ranging from 1-100 based 
on ratings of functioning in four areas: socially useful activities, relationships, self-care, and 
disturbing behaviors. Scores falling within 71-100 indicate mild or no difficulty and is often 
considered indicative of objective recovery. The SAS-II offers two scores of social functioning: 
social and leisure functioning, which reflect level of social activities and meaningfulness of 
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interpersonal relationships; and instrumental role performance, which offers information about 
the consistency and effectiveness of role performance.     
In an effort to integrate these measures, Liberman et al. [40] have proposed recovery be 
reflected by ratings of moderate or less on the BPRS symptom scales coupled with part time 
work or satisfactory role function, independent living and active social connections over a two-
year period. This approach thus allows that recovery can occur despite higher symptoms levels 
than those specified in the Andreasen [35] criteria. 
1.3 Methodologies for Defining Recovery as Subjective Process 
Quantifying recovery as a subjective process is complicated, as it involves capturing a 
deeply personal process in a way that allows for comparisons between persons. Despite this 
challenge, several qualitative studies have explored how persons with SMI identify recovery 
with a fair degree of consistent results. In a study of 58 individuals with SMI, Schӧn and 
colleagues [41] found that social connection was the overall most important aspect of recovery 
identified by persons diagnosed with SMI. This is consistent with Topor et al. [42], who 
concluded based on qualitative analyses that recovery is experienced primarily in a social 
context. It is also consistent with findings that negative social experiences are a barrier to 
recovery later in life as they complicate these forms of social connection. Evidence of this 
includes studies by Stumbo et al. [43] who found that a history of adverse social events, 
including abuse and neglect in childhood, were predictors of lower levels of recovery from SMI 
in adulthood and Gumley et al. [44] who found attachment style was related to subjective 
recovery. Cotton and Loewenthal [45] interviewed 8 persons diagnosed with SMI and reported 
that subjective recovery involved understanding the meaning of psychotic experiences, the 
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creation of alternatives to the medical model (i.e., instilling hope rather than viewing SMI 
chronically), and sustaining social supports. 
Leamy and colleagues [46] compiled results from several such studies and noted 
recurrent themes across countries that individuals with SMI describe recovery as consisting of 
connectedness to others, hope for the future, a sense of identity, feeling empowered to make 
one’s own decisions, and the sense of a meaningful life. Jose et al. [47] similarly reviewed 25 
studies that interviewed consumers across Europe, the US, and Australia and noted themes of 
recovery as a non-linear process, an understanding of oneself, social connectedness, and an 
improvement in functioning that occurred without continuing treatment. Connell et al. [48] 
interviewed 20 persons with first episode psychosis (FEP) and reported recovery involved two 
processes closely related to meaning making, with greater subjective recovery related to the 
development of personally meaningful interpretation of the experience of SMI, strengthened 
relationships with others, and more cohesive sense of self. De Wet et al. [49] analyzed interviews 
of seven participants experiencing FEP and reported recovery involved rejecting stigma and 
recapturing a previously held sense of agency and sense of self. More recently, Yarborough et al. 
[50] performed qualitative analyses of 177 participants with a range of different forms of SMI.
They concluded that recovery involved managing loss and gaining control over one’s life. They 
describe “getting by” or meeting basic needs and responding to stressors and “getting back” 
which reflected a life in which mental illness played no significant role. Taken together, the 
results from these qualitative studies suggest that making meaning of one’s experiences and 
sense of self and gaining agency is important in moving toward recovery. 
Informed by clients’ experiences, efforts have been made to create self-report 
questionnaires that assess dimensions of recovery identified as important to persons with SMI. 
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For purposes of this review, we will discuss the most widely cited and validated instruments. The 
most popular of these is the Recovery Assessment Scale [RAS; 51,52]. The RAS is a self-report 
measure that assesses self-perception of recovery developed from narratives of individuals with 
mental illness, with the final items being reviewed by individuals with SMI [52]. The scale 
consists of 41 items, providing a total score as well as five subscales thought to reflect elements 
of subjective recovery: personal confidence and hope, willingness to ask for help, goal and 
success orientation, reliance on others, and no domination by symptoms [53]. Acceptable 
reliability and validity have been reported [53-55] along with correlations with other established 
measures such as the Hope Herth Index, Empowerment Scale, Subjective Quality of Life, 
Meaning of Life, and Hopkins Symptom Checklist [53,56,57]. A 20-item form of the RAS has 
been developed [58] and it has been translated and studied in many languages, including 
Japanese [56], Chinese [59], and Portuguese [60]. 
While reviews of subjective recovery assessments lament the lack of a gold standard, 
many authors have concluded that the RAS may be the best current option due to it possessing 
validity via constructs developed with clients and adequate psychometric properties [56,57,61]. 
Criticisms of the RAS include that it may not be able to differentiate among individuals in 
different stages of recovery, may not capture all dimensions of recovery, such as social 
functioning [62] and that it neglects some  aspects of recovery prominent in first person 
accounts, including reciprocity [63,64].  
Other measures identified as possessing potential to assess subjective recovery include: 
Illness Management and Recovery Scale [IMR; 65], Mental Health Recovery Measure [MHRM; 
66], Psychosis Recovery Inventory [PRI; 67], Questionnaire about the Process of Recovery 
[QPR; 68], Recovery Process Inventory [RPI; 69], and Stages of Recovery Instrument [STORI; 
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70]. Questions have been raised about these scales’ suitability for research due to psychometric 
limitations or complicated administration procedures [56,57].  Detailed analyses of these and 
other less prominent instruments have been presented elsewhere [56,57,61].  
1.4 Rate of Recovery as an Objective Outcome and Predictive factors 
One benefit of focusing on recovery as an objective outcome is that recovery rates can be 
captured and illness course more carefully tracked. This type of data is not available for 
subjective recovery, as no end state can be delineated. There are several tools designed to 
measure objective recovery and we have presented the most used and validated instruments. 
Summarized in Table 1 are the general findings from 34 studies published between 2008 and 
2016 for people in both early and later phases of illness which tracked whether or not they 
achieved objective recovery. Fourteen studies present rates of symptom remission, three present 
rates of the achievement of psychosocial function, and seventeen offer rates of both in the same 
sample. 
Starting with the 10 studies examining FEP, Table 1 shows that these had follow-up 
periods from 6 months to 10 years. Rates of symptom remission ranged from 37-91.4% while 
rates of healthy psychosocial functioning ranged from 29-58%, and rates for achieving both 
symptom remission and psychosocial functioning ranged from 14-29.5%. Considered as a whole, 
the average rates of recovery from FEP were 64.5% for symptom remission, 39.7% for healthy 
psychosocial functioning, and 21.0% for those achieving both symptom remission and 
psychosocial functioning. 
The remaining 24 studies examined persons in prolonged phases of illness. The tracking 
periods for these studies ranged from cross sections with a single assessment up to 20 years 
follow-up. The first of the two studies with 20-year follow-up periods was Goghari and 
 14 
colleagues [71] who examined 150 individuals. They reported that 40-45% continued to 
experience hallucinations, and that those experiencing hallucinations early in the course of 
illness were less likely to achieve symptom remission. Harrow and colleagues [72] examined 139 
individuals also over a period of 20 years and reported that only 12 participants were symptom 
free at every assessment during that period, but 40% achieved both symptom remission and 
concurrent healthy psychosocial functioning during at least one of their assessments over 20 
years. The remaining 22 reviewed studies reported rates of 37-89% for symptom remission, 21-
53% for adequate psychosocial functioning, and 13-27 % for both symptom remission and 
psychosocial functioning criteria. Considered as a whole, the cross-study average rates for 
persons with more prolonged illness were 50.57% for symptom remission, 25.0% for 
psychosocial functioning, and 18.57% for both symptom remission and psychosocial 
functioning. 
Concerning correlates of achieving recovery as an outcome, several studies note the 
importance of negative symptoms, which were repeatedly associated with being less likely to 
achieve objective recovery [73-75]. Shorter duration of untreated psychosis was also associated 
with achieving recovery as an outcome for individuals with FEP [75,76]. Conflicting findings 
exist for the role of cognitive functioning, as Hofer et al. [77] found that in 140 individuals 
diagnosed with schizophrenia, superior frontal lobe functioning was associated with 
experiencing symptom remission, while Brissos et al. [78] found no correlation between 
cognitive functioning and symptom remission in 76 individuals diagnosed with schizophrenia. 
Verma et al. [75] examined 1175 individuals with FEP and found female gender, younger age, 
marriage, and tertiary education to all be predictors of objective recovery.  
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Of note, studies found conflicting information about the role of antipsychotic medication 
being associated with rates of symptom remission. In their study of 268 people diagnosed with 
schizophrenia, Barak and Aizenberg [79] reported rates of symptom remission were significantly 
higher for those treated with an injectable medication over 6 months than for those taking oral 
antipsychotics. Tiihonen and colleagues [80] similarly found that individuals treated with 
injectable medications experienced less relapse in psychotic symptoms than those treated with 
oral medications, but also note that in their study of a nationwide database of 29,823 patients 
treated with antipsychotic medications in Sweden, 71.7% still experienced treatment failure 
(defined as hospitalization, suicide attempt, discontinuation of that medication, or switching to a 
different medication). In contrast, Harrow and colleagues [72] found that, in a period of 20 years, 
of 139 individuals over 70% of those who were treated with antipsychotic medication continued 
to experience psychotic symptoms, while those not treated with antipsychotic medications 
experienced significantly less enduring psychotic phenomena. Conus et al. [81] examined 
outcomes of over 100 clients consistently declining medication over a treatment trial and found 
41% of that group experienced symptom remission while a third reached their definition of 
functional recovery, which included symptom remission as defined by a score “3” or lower on 
the CGI, and functional recovery, as defined by having regular activity and living independently. 
A study by Wunderink et al. [82] may offer an explanation of the mixed findings regarding the 
link between recovery and anti-psychotic medication. They conducted follow-up studies with 
103 individuals with FEP, randomizing half to receive either a discontinued or reduced dose of 
antipsychotics after six months of symptom remission, or to receive maintenance doses of 
antipsychotic medication. They found that individuals receiving the discontinued/reduced dose 
of antipsychotics experienced twice (40.4% vs 17.6%) the rate of recovery (defined as both 
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symptom remission and psychosocial functioning) than individuals who received the 
maintenance dose. Wunderink and colleagues [82] interpreted these findings as suggesting that 
while antipsychotic medication may be linked with higher rates of acute symptom remission, it 
may also be linked with poorer long term outcomes.   
Importantly, current research on recovery as an objective outcome exhibits multiple 
limitations. The ranges of objective recovery rates are large and the literature provides scant 
detail about the characteristics of people who are experiencing remission. It remains unclear how 
to integrate the findings from studies that assess outcome at 6 months with others that assess 
outcome at 20 years. Importantly, it is unclear which studies represent the spectrum of 
individuals who experience SMI, as individuals who never receive formal treatment or who 
quickly recover and drop out of treatment are rarely enrolled in research. 
1.5 The Relationship of Objective and Subjective Forms of Recovery  
While the majority of studies reviewed employed either an objective or subjective 
definition of recovery, some have explored whether achieving recovery as an outcome is related 
in any way to recovery as a process. Many of these have explored whether the subjective 
experience of recovery is related to symptoms. Roe et al. [83] investigated whether subjective 
reports of recovery using the RAS along with subjective reports of quality of life (QoL) were 
correlated with objective assessments of symptom severity using the BPRS and GAF in 159 
individuals with SMI. They found that mood disturbances were related to lower QoL and lower 
hope on the RAS. Additional analyses indicated that the relationship between total symptom 
score and total score of subjective recovery was moderated by age of onset, while the impact of 
social support and loneliness upon self-reported recovery was mediated by QoL. Jorgensen et al. 
[84] examined the relationship of four assessments of symptoms with four assessments of self-
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reported aspects of recovery over the course of one year among 101 individuals with 
schizophrenia. In contrast to the findings of Roe et al. [83], analyses revealed the total symptom 
score of the PANSS was linked with lower levels of overall subjective recovery on the RAS at 
all four measurement points, though the strength of that relationship varied, being strongest at 
baseline three and twelve months but quite weak at six months. Symptoms of anxiety, 
depression, and guilt were most closely linked with lower levels of self-reported recovery. 
Emotional discomfort and negative symptom PANSS components made independent 
contributions to the prediction of the RAS total. 
Morrison et al. [85] examined concurrent assessments of psychological functioning, 
insight, symptoms, neurocognition, and subjective recovery from psychosis in 122 adults. They 
found emotional distress and a lack of sense of control had direct effects on the self-experience 
of recovery, while positive symptoms directly impacted recovery, mediated by emotional 
distress. Recovery was not significantly linked with neurocognition, insight, or negative 
symptoms. Law et al. [86] examined longitudinal predictors of subjective recovery among 100 
participants with psychosis and included measures of symptoms, self-esteem, and hope. They 
found that current levels of subjective recovery were related to lower levels of emotional 
distress, higher self-esteem and hope, and to a lesser extent, more objective measures of 
functioning and symptom severity. Eisenstadt et al. [87] interviewed 16 participants with FEP 
and found that subjective recovery was linked to the decrease of psychotic symptoms concurrent 
with growth in a sense of personal agency, control over one’s life, and social connectedness. 
MacBeth et al. [88] similarly reported that quality of life was related to levels of 
symptoms and premorbid adjustment among a sample in Scotland with FEP. Beck et al. [89] 
gathered self-report assessments of symptoms and self-experience of recovery among 122 
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participants with SMI in the United Kingdom. The authors note different thresholds for the 
experience of recovery, but found wellness was linked with the experience of lower levels of 
anxiety and depression. Of note, cultural differences between these studies may be important as 
Hofer et al. [90] has reported that the links of symptoms to measures of stigma, self-esteem, and 
hope was stronger in a sample of persons with schizophrenia from Austria as opposed to a 
sample from Japan. 
Focusing on the relationship of subjective recovery to objective levels of function, 
Oliveira-Maia and colleagues [91] have examined the relationship between the MHRM, a self-
report measure of recovery, with the GAF, QoL, and self and clinician rated assessments of 
social needs in 101 individuals with SMI. They found that scores on the MHRM were correlated 
with each of these other scores. Norman et al. [92] examined the relationship between 
objectively related symptoms and measures of subjective recovery including the RAS and the 
Modified Engulfment Scale and measures of social support among 84 persons with FEP. 
Subjective recovery was found to be more closely associated with the perception one will be 
valued by others than with symptoms. A review conducted by Charzynska et al. [93] of 18 
studies found that employment was associated with markers of subjective recovery. Hendryx et 
al. [94] examined functional correlates of the RAS in 153 participants diagnosed with SMI and 
found better subjective recovery was related to more social connection. A recent study (n=2842) 
reported that subjective QoL was a significant predictor of the "objective" event of future 
hospitalization, with lower QoL being associated with higher risk of hospitalization, within 6 
months and self-report of the impact of symptoms on functioning significantly predicted 12-
month hospitalization controlling for known risk factors [95].Taking a different approach, 
Wciorka et al. [96] assessed the stage of recovery among 110 persons with SMI using the STORI 
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[70]. Participants assessed at higher stages of the recovery process tended to have both fewer 
symptoms and a richer sense of self less linked with mental illness. This is consistent with 
Windell et al. [97] who interviewed 30 individuals with FEP and reported recovery involved 
symptom remission, the chance to make personal meaning of illness, and a sense of control over 
one’s life. 
Examining other objectively assessable factors potentially related to subjective recovery, 
Werner [98] performed path analyses of assessments of wellbeing, needs, and hope among 172 
individuals with SMI, revealing hope as the most powerful predictor of subjective recovery. In a 
study of 46 adults with SMI, Kukla and colleagues [99] found higher metacognitive capacity, or 
the ability to have complex thoughts about self and others, was related to less domination by 
symptoms and enhanced abilities to seek help from others, as measured by the RAS. This effect 
remained when controlling for symptoms. Thomas et al. [100] studied 250 individuals diagnosed 
with SMI and reported that social support domains, such as size of social network, were related 
to both subjective and objective markers of recovery. Notably, their results showed self-efficacy 
was the mediator between social support domains and subjective and objective recovery.  
Other data suggest that subjective recovery is not a consequence of objective recovery, 
but is instead a protective factor. Kukla et al. [101] examined the link between subjective 
recovery using the RAS with objective rating of symptoms using the PANSS and objective 
ratings of the social components of quality of life using the Heinrichs’s et al. [102] Quality of 
Life Scale. Participants were 68 veterans with SMI. No significant correlations were found 
between self-reported recovery and symptom assessments. They found, however, that levels of 
subjective recovery moderated the relationship between the two objective measures: the 
relationship of positive symptoms and social functioning. Specifically, participants with greater 
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RAS total scores and more positive symptoms had greater capacity for social relatedness and 
instrumental function compared to participants who had high levels of positive symptoms but 
lower levels of self-reported recovery. These moderating effects remained significant after 
controlling for ratings of negative symptoms. This finding was similar to Cavelti et al. [103] who 
assessed mood and subjective wellness among 142 adults with schizophrenia. They suggested 
the experience of recovery had a protective effect such that greater awareness of illness did not 
result in depression.  
Lysaker et al. [104] proposed an integrative approach to defining and measuring 
recovery, suggesting recovery could be understood in terms of externally observable objective 
outcomes and two distinct subjective outcomes: i) the subjective appraisal of one's life 
circumstances and opportunities and ii) the subjective experience of oneself as an individual 
human being. They argue that this conceptualization allows for understanding recovery as a 
complex process in which life events and the meanings persons bestow to them influence the 
experience of illness and wellness. This is consistent with recent work pointing out how agency 
may interact with sense of self, resulting in a complex path from experience to agency to the 
experience of a multifaceted, cohesive sense of self culminating in self-directed recovery [105]. 
Importantly, as described by Hasson-Ohayon and colleagues [106], the complex nature of 
recovery best lends itself to be studied via mixed-methods design so as to capture a range of data 
that offers information about a multifaceted phenomenon. 
1.6 Summary and Conclusions 
While the idea of recovery is far from integrated within  mainstream psychiatry, as is 
illustrated by its absence in the DSM 5 [107], abundant evidence exists showing recovery is 
possible and in fact a likely outcome for those with SMI. Nevertheless, significant divisions 
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remain regarding how recovery should be characterized. Considered as an outcome, recovery 
involves symptom remission and the attainment of psychosocial milestones. Considered as 
process, recovery has been described as including many aspects of self-experience related 
variables, such as sense of identity. Measured as an outcome, rates of recovery are promising, 
but vary dramatically across studies and research about the outcomes for persons who refuse or 
do not seek services is sorely lacking. Measured as a process, recovery is obtainable over time, 
although what this consists of will be unique to each individual. While the relationship between 
indicators of both forms of recovery is inconsistent across studies, the two seem to be related and 
it does seem clear that objective indicators of emotional distress are related to subjective 
appraisals of recovery. 
2. Expert Commentary 
Two questions emerging from this review are why this division persists and whether 
views of recovery as an outcome and recovery as a process have anything in common? In 
response to the question about why these views persist, we suggest the root of the difference may 
be attributed, in part, to providers of mental health services and persons with SMI being 
concerned with different aspects of SMI. Providers appear focused on what they and others 
perceive as odd and unusual experiences, paucity of internal experience, and psychosocial 
impairments. Alternatively, persons diagnosed with SMI are concerned with loneliness, stigma, 
loss of personal identity, and feeling that others do not hold them in esteem. Accordingly, 
recovery from these different views is defined as the resolution of different issues, and in fact our 
use of the terms “objective” and “subjective” to define recovery seems at heart to be referring to 
whether recovery is defined by an outside person or by the individual experiencing the illness.  
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In response to the question of whether these views have anything in common, we suggest 
they share at least two things in common which have far reaching implications. First, both 
perspectives emphasize that persons with SMI must make decisions about the meaning of the 
challenges they face in order to recover. If an objective view of recovery is utilized, persons with 
SMI must first decide that they are in fact ill and could benefit from treatment that may 
ameliorate symptoms. They might decide, for example, that a certain symptom means that they 
have an illness for which there may be treatment. If a subjective definition is utilized, to establish 
a satisfactory quality of life and sense of self as more than a mental patient, persons with SMI 
must engage in making meaning of their challenges. This requires that meaning making account 
for unique history, including social connections, ethnic and cultural background, sense of 
community, personality, etc. In both of these views of recovery, the person in the center is 
required to make decisions that could lead to recovery, and this includes making meaning of 
psychiatric challenges. While the nature of these decisions and the requisite meaning making 
differs, an individual must still have agency and make sense of their experiences.  
A second point of agreement between differing models of recovery is that there are many 
threats to making sense of experiences that accompany SMI. In both perspectives, persons with 
SMI may struggle to make sense of the objective and subjective elements of recovery in the face 
of anomalous experiences, demoralization, metacognitive deficits, stigma, trauma, poverty, etc. 
Providers also face threats to engaging in meaning making with consumers, including anxiety 
that is often provoked by sitting with someone who may be in a dysregulated or actively 
psychotic state, heightened institutional concern over safety, and stigmatized beliefs about SMI. 
Certainly, crises can emerge in which firm action is needed (e.g. acute risk for self-harm). What 
we are describing here, however, is an insidious process in which clinicians lose or fail to 
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establish the idea that a unique individual can get to a place of directing personal recovery and 
that providers’ concern over issues of insight or safety lead them to be unwilling to engage in 
recovery oriented tools that are available to them, such as shared decision making [108,109] and 
advanced psychiatric directives.  
Conceptualizing recovery as involving meaning making in the face of multiple threats has 
many implications. We will focus on four clinical implications. First, it requires recovery 
oriented treatments assume that psychotic experiences are human experiences able to be 
understood [110] and that persons with SMI can form and evolve those meanings. Naturally, 
symptoms will occur within the course of treatment. Providers must then respond to consumers’ 
unusual thoughts and experiences as potentially meaningful and not something to be treated or 
extinguished before understanding can be established. Thus, in the course of an interaction, the 
emergence of an odd belief is understood as possessing any number of potential meanings, 
consistent with research suggesting that symptoms do not randomly emerge, but can be tied to 
clear antecedents [111], and can be understood as being linked with emotional pain [112,113]. 
This requires recovery oriented treatment to cast persons with SMI as active agents in their own 
recovery in all phases of illness, allowing for people to create their own meanings given their 
own unique circumstances.  
Second, recovery oriented care accordingly requires complex reflections and is likely to 
be more about process than specific content. Meaning making does not rule out or advantage any 
specific interventions. Instead, it requires that regardless of content, interventions are used to 
promote understanding. For example, psychoeducation, case management, or psychotherapy 
would be recovery oriented if they were stimulating and supporting reflection, that is helping 
persons with SMI to decide something about their experiences. They would not be recovery 
24 
oriented, however, if they were instead telling persons what to think and accept. Thus, the format 
of treatment may be less important than that it is being jointly used to make meaning. 
Third, if making meaning is at issue, the relationship of the provider to the recovering 
person must be non-hierarchical. What is required of recovery oriented care is dialogue and the 
rejection of stigma. This is not to deny provider expertise, but that the offer of expertise is in line 
with the wishes of persons with SMI. Importantly, providers do not need to agree with all that 
persons with SMI say or believe. Dialogue requires a conversation between two differing 
perspectives [106] and requires that the therapeutic relationship be dynamic and changing as 
both client and provider grow in the therapeutic process [114]. It may occur that providers 
believe that a consumer is not “ready” for recovery and thus make decisions about what is and it 
not possible for the consumer. This clearly goes against a recovery oriented approach and 
assumes that providers, due to their expertise or lack of impairment as compared to an individual 
experiencing SMI, have a more objective view of reality. Such notions must be pushed against 
and providers must genuinely partner with consumers to assist them in moving toward recovery.  
Finally, with meaning making pain may emerge. As persons form an increasingly 
complex sense of themselves awareness of loss linked with SMI may emerge and persons may 
struggle to replace comfortable, albeit stigmatized, ideas about themselves. Pain with meaning 
making may also emerge due to the real implications of stigma and the ways in which people 
with SMI are marginalized [115], as well as the increased rates of depression and suicide in 
individuals who experience SMI [116].  Thus, treatment must consider these forms of 
transformation as complex and unpredictable.  
3. Five Year View
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 Over the next five years, the field awaits further development of conceptualizing meaning 
making as essential to recovery and recovery-oriented treatment. This requires development of 
ways to measure recovery that involves persons with SMI first coming to terms with their own 
experiences and also the perspectives of others. Recovery, as a concept and a treatment 
orientation, must evolve from forms that consider it the removal of a disease state to views that 
include living with and making sense of pain while still living a meaningful life. To assist 
persons in this process, providers and other helpers must be sensitive to issues of power and to 
not privilege their knowledge as being more valid. To fully embrace the idea of recovery, 
providers and researchers must reject paternalism and abandon the longstanding belief that 
wellness results from following orders and taking medication. Possibility for recovery has been 
confirmed empirically, including studies that show wellness over a period of 20 years was not 
related to taking antipsychotic medication [72,117]. Yet, our field holds onto the idea that 
treatment providers know how and when people will get better because it is reassuring and 
reduces the anxiety of both the provider and client. Mental health care cannot be synonymous 
with seeing clients as clusters of symptoms and attempting to get them to adhere to what we 
think is best. Undoubtedly, there are catastrophic elements to SMI, and those who experience it 
suffer profoundly at points in their lives. Embracing recovery does not deny suffering, or reject 
the notion that providers have expertise to offer their clients. Even amongst subjective definitions 
of recovery, there must be some consensually valid aspects to a person’s recovery, and it must be 
rooted in the larger community view. For example, someone lacking in relationships, resources, 
or any fulfilling life roles who denies any problems would not seem to be meaningfully moving 
toward subjective recovery. At the heart of these conditions, suffering exists and can often be 
profound. However, available science and contemporary treatments continue to struggle with 
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how to offer care in a way that balances expertise, acknowledges the profound suffering of those 
with SMI, and still supports personal choice and mastery in a unique life. The field must embrace 
heterogeneity of outcomes for those with SMI and fight against professional pessimism about 
what is possible. Providers and researchers must find ways to concretize the balance between 
dignity of risk and duty to treat. 
 Additionally, meaning making at the core of the recovery process calls for efforts to 
promote and develop integrative treatments that focus on the process of meaning making rather 
than sole focus on content (i.e., seeing the incorrectness of a delusion). It is the process of 
making meaning out of experiences that seems to promote agency and plays a pivotal role 
beyond the distinction of objective and subjective elements, as the process itself seems 
transformative. Accordingly, therapeutic attempts should be sensitive to the need to make sense 
of experience and encourage a sense of agency within the client [118]. Notably, a therapeutic 
alliance in which the therapist and clients work together in an intersubjective space is needed for 
the client to discover his or her own meaning [106,114]. There are also many areas that may be 
related to recovery that need to be explored and incorporated into integrative treatments, 
including neurocognition, metacognition, and social cognition. Similarly, there are elements that 
seem to be correlates of subjective recovery, such as hope and self-esteem, that are mentioned in 
the literature but further understanding of their role would be beneficial to inform integrative 
treatments. 
 Finally, as the field seeks to understand and promote recovery, it is essential to 
incorporate individuals who leave treatment or who do not engage in treatment at all. Certainly, 
the experiences of these individuals offer valuable information to the understanding of the 
intersection between recovery and the mental health system. People who leave or refuse 
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treatment are likely a heterogeneous group with a multitude of different outcomes and reasons 
for electing to not be involved in the mental health system. Understanding the complexity within 
this group will assist the field in developing a more inclusive and comprehensive 
conceptualization of paths to recovery and the role of mental health services.  
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Key Issues 
•  Recovery continues to be a complex construct in the exploration, conceptualization, and 
treatment for serious mental illness (SMI) and continues separately discussed as a 
subjective process or an objective outcome. 
•  Regardless of how recovery is defined, there is abundant evidence that the outcomes for 
those with SMI are heterogeneous, and that and that recovery is the most common 
outcome. 
•  Divergent views of what recovery means seem to persist in part due to providers and 
people with SMI being concerned about different elements of SMI. Providers seem to be 
concerned with the presence of odd or unusual experiences and psychosocial 
impairments. Persons with SMI are most concerned with loneliness, stigma, and loss of 
personal identity. 
•  Despite the differences inherent in these two conceptualizations of recovery as a process 
or an outcome, making meaning out of confusing experiences and accepting sense of 
personal agency seems to be essential in either form of recovery.  
•  There are several threats to meaning making that providers and persons with SMI must 
contend with, including symptoms experienced and demoralization that may accompany 
experiencing a serious mental illness. 
•  This offers at least four clinical implications for recovery oriented care: i) recovery 
oriented treatments must assume that psychotic experiences are understandable; ii) 
recovery oriented care requires complex reflections and must promote reflection and not 
tell persons with SMI what to think; iii) the relationship between provider and client must 
create and foster a consultant, non-hierarchical relationship; and iv) recovery oriented 
care must acknowledge and anticipate pain that comes with the process of recovery.  
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